How polyunsaturated fatty acids modify molecular organization in membranes: insight from NMR studies of model systems

Abstract

Marine long chain n-3 polyunsaturated fatty acids (PUFA), eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), are bioactive molecules with clinical applications for the treatment of several diseases. In order to effectively translate these molecules into clinical trials, it is essential to establish the underlying mechanisms for n-3 PUFA. This review focuses on efforts to understand how EPA and DHA, upon incorporation into plasma membrane phospholipids, remodel the molecular organization of cholesterol-enriched lipid microdomains. We first give an overview of results from studies on cells. Paradoxical data generated from mouse studies indicate that EPA and DHA incorporate into lipid microdomains, yet in spite of their high disorder increase molecular order within the domain. We then spotlight the utility of solid state (2)H NMR spectroscopy of model bilayers as a tool for elucidating underlying mechanisms by which n-3 PUFA-containing phospholipids can regulate molecular organization of lipid microdomains. Evidence is presented demonstrating that n-3 PUFA exert differential structural effects when incorporated into phosphatidylethanolamines (PE) compared to phosphatidylcholines (PC), which explains some of the conflicting results observed in vivo. Recent studies that reveal differences between the interactions of EPA and DHA with lipid microdomains, potentially reflecting a differential in bioactivity, are finally described. Overall, we highlight the notion that NMR experiments on model membranes suggest a complex model by which n-3 PUFA reorganize lipid microdomains in vivo.

Keywords: Docosahexaenoic acid (DHA); Eicosapentaenoic acid (EPA); Lipid microdomain; Lipid raft; Solid state (2)H NMR.